Halozyme partners with Oruka for psoriasis drug development deal
Go back to Halozyme partners with Oruka for psoriasis drug development deal| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 71.15 +1.53 (2.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.62 | 52 Week High | $18.39 | |||
| Open | $70.12 | 52 Week Low | $6.96 | |||
| Day High | $71.87 | P/E | N/A | |||
| Day Low | $69.73 | EPS | $-0.58 | |||
| Volume | 1,945,892 | |||||
| (NASDAQ: ORKA) | Delayed: 82.09 -1.31 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $83.40 | 52 Week High | $ | |||
| Open | $81.99 | 52 Week Low | $ | |||
| Day High | $85.68 | P/E | N/A | |||
| Day Low | $80.42 | EPS | $ | |||
| Volume | 1,640,915 | |||||
